Ceasing Cervical Cancer
GlaxoSmithKline has granted an unrestricted gift to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation, to focus research efforts on cervical-cancer prevention.
Hardly a Shot in the Dark
A study from the University of Maryland has found that few eligible young women choose to take the HPV (human papillomavirus) vaccine, and, of those who do, relatively few take the recommended three doses. HPV is a known cause of cervical cancer.